Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Miller Richard A Md
Relationship:   Director
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   893,366    

Indirect Shares

  1,214,771      
Direct Value   $1,326,047    

Indirect Value

  $2,685,113      
Total Shares   2,108,137      
Total Value   $4,011,160      


Pharmacyclics Inc
 $0 Corvus Pharmaceuticals, Inc.
 $1,305,453 Bolt Biotherapeutics, Inc.
 $20,595 Pharmacyclics Inc
 $0 Corvus Pharmaceuticals, Inc.
 $1,305,453 Bolt Biotherapeutics, Inc.
 $20,595
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    15   
    0    

     Stock price went up :

    6   
    0    
     Stock price went down :
    9   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   41.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Pres, CEO & Director, ... 2007-08-22 300,130 2007-08-22 26,668    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS 2024-05-10 577,634 2024-05-10 1,188,103    Premium*  
            Bolt Biotherapeutics, Inc. BOLT Director 2021-02-04 15,602 0    Premium*  
* Premium Members only  

Records found :    48         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2003-10-31 4 B $4.79 $2,344 D/D 489 259,383 2.73 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2004-04-30 4 A $4.93 $4,930 D/D 1,000 260,383 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2004-10-29 4 A $4.93 $4,930 D/D 1,000 261,383 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2005-04-29 4 A $4.93 $4,930 D/D 1,000 262,383 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2005-08-01 4 D $9.25 $1,100,010 D/D (118,920) 143,463 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2005-08-01 4 OE $7.50 $1,100,003 D/D 146,667 290,130 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2007-08-21 4 B $2.00 $10,008 D/D 5,000 295,130 2.81 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2007-08-22 4 B $2.00 $10,000 D/D 5,000 300,130 2.81 -
CRVS Corvus Pharmaceuticals, I... President and CEOOfficer   •       •      –    2016-03-22 3 IO $0.00 $0 I/I 0 718,228 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-03-29 4 A $0.00 $0 I/I 328,765 1,046,993 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-05-12 4 B $10.00 $300,000 I/I 30,000 1,076,993 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-05-13 4 B $9.94 $2,981 I/I 300 1,077,293 2.58 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-10-28 5 GD $0.00 $0 I/I 100,000 977,293 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-06-09 4 B $9.89 $87,174 I/I 8,784 986,077 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-06-12 4 B $9.82 $110,185 I/I 11,216 997,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-06-13 4 B $9.75 $49,725 I/I 5,000 1,002,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-11-20 4 B $10.79 $107,850 I/I 10,000 1,012,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-03-12 4 B $8.50 $850,000 I/I 100,000 1,112,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-04 4 B $5.95 $8,937 I/I 1,502 1,113,795 2.58 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-06 4 B $5.99 $29,934 I/I 5,000 1,118,795 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-11 4 GD $0.00 $0 I/I 20,000 1,098,795 0 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-20 4 B $4.39 $43,950 I/I 10,000 1,108,795 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-27 4 B $3.29 $65,884 I/I 20,000 1,128,795 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-06-07 4 B $3.37 $31,019 I/I 9,212 1,138,007 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-06-11 4 B $3.67 $22,020 I/I 6,000 1,144,007 2.58 -

  48  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed